￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Medical drugs

Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What are the risks and preventive measures for relapse after discontinuation of Vigabatrin (vigabatrin)?

2026-02-01 22:25:32

Check Details
How to monitor treatment response and evaluate efficacy of Mobotinib

2026-02-01 22:25:32

Check Details
Discussion on the risk of recurrence after discontinuation of Tepotinib and the safe withdrawal plan

2026-02-01 22:25:32

Check Details
Introduction to the risk of liver function injury and monitoring plan of Regorafenib

2026-02-01 22:25:32

Check Details
Comparison of the efficacy of pazopanib and other targeted drugs and suggestions for selection

2026-02-01 22:25:32

Check Details
Study on the effects of long-term use of Opicapone on liver and kidney function

2026-02-01 22:25:32

Check Details
Finerenone dosage adjustment and analysis of individualized treatment plans

2026-02-01 22:25:32

Check Details
Clinical research progress of rasagiline in the treatment of early Parkinson's disease

2026-02-01 22:25:32

Check Details
Is Pralsetinib included in the medical insurance reimbursement catalog?

2026-02-01 22:25:32

Check Details
Is capmatinib suitable for patients with MET14 exon skipping?

2026-02-01 22:25:32

Check Details
Is Sotorasib suitable for patients with brain metastases?

2026-02-01 22:25:32

Check Details
What is the difference between Adagrasib and Sotoprasib?

2026-02-01 22:25:32

Check Details
Category
相关知识